[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Chronic Refractory Cough (CRC) Treatment Market Growth (Status and Outlook) 2023-2029

March 2023 | 89 pages | ID: G61B5C1D155CEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Chronic refractory cough (CRC) refers to cough that persists after treatment according to guidelines. Among the patients who went to the cough specialist clinic, 20% to 46% had chronic refractory cough, and the quality of life and health of these patients were greatly affected.

LPI (LP Information)' newest research report, the “Chronic Refractory Cough (CRC) Treatment Industry Forecast” looks at past sales and reviews total world Chronic Refractory Cough (CRC) Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Chronic Refractory Cough (CRC) Treatment sales for 2023 through 2029. With Chronic Refractory Cough (CRC) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Refractory Cough (CRC) Treatment industry.

This Insight Report provides a comprehensive analysis of the global Chronic Refractory Cough (CRC) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Refractory Cough (CRC) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chronic Refractory Cough (CRC) Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Refractory Cough (CRC) Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Refractory Cough (CRC) Treatment.

The global Chronic Refractory Cough (CRC) Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Chronic Refractory Cough (CRC) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Chronic Refractory Cough (CRC) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Chronic Refractory Cough (CRC) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Chronic Refractory Cough (CRC) Treatment players cover Merck, Nerre Therapeutics, Bellus Health, Attenua, Respivant Sciences and Shionogi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Refractory Cough (CRC) Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Speech Therapy
  • Physiotherapy
Segmentation by application
  • Hospital
  • Clinic
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Merck
  • Nerre Therapeutics
  • Bellus Health
  • Attenua
  • Respivant Sciences
  • Shionogi
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Chronic Refractory Cough (CRC) Treatment Market Size 2018-2029
  2.1.2 Chronic Refractory Cough (CRC) Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Chronic Refractory Cough (CRC) Treatment Segment by Type
  2.2.1 Speech Therapy
  2.2.2 Physiotherapy
2.3 Chronic Refractory Cough (CRC) Treatment Market Size by Type
  2.3.1 Chronic Refractory Cough (CRC) Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Type (2018-2023)
2.4 Chronic Refractory Cough (CRC) Treatment Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Chronic Refractory Cough (CRC) Treatment Market Size by Application
  2.5.1 Chronic Refractory Cough (CRC) Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Application (2018-2023)

3 CHRONIC REFRACTORY COUGH (CRC) TREATMENT MARKET SIZE BY PLAYER

3.1 Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Players
  3.1.1 Global Chronic Refractory Cough (CRC) Treatment Revenue by Players (2018-2023)
  3.1.2 Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Chronic Refractory Cough (CRC) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CHRONIC REFRACTORY COUGH (CRC) TREATMENT BY REGIONS

4.1 Chronic Refractory Cough (CRC) Treatment Market Size by Regions (2018-2023)
4.2 Americas Chronic Refractory Cough (CRC) Treatment Market Size Growth (2018-2023)
4.3 APAC Chronic Refractory Cough (CRC) Treatment Market Size Growth (2018-2023)
4.4 Europe Chronic Refractory Cough (CRC) Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Chronic Refractory Cough (CRC) Treatment Market Size by Country (2018-2023)
5.2 Americas Chronic Refractory Cough (CRC) Treatment Market Size by Type (2018-2023)
5.3 Americas Chronic Refractory Cough (CRC) Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Chronic Refractory Cough (CRC) Treatment Market Size by Region (2018-2023)
6.2 APAC Chronic Refractory Cough (CRC) Treatment Market Size by Type (2018-2023)
6.3 APAC Chronic Refractory Cough (CRC) Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Chronic Refractory Cough (CRC) Treatment by Country (2018-2023)
7.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type (2018-2023)
7.3 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Chronic Refractory Cough (CRC) Treatment by Region (2018-2023)
8.2 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CHRONIC REFRACTORY COUGH (CRC) TREATMENT MARKET FORECAST

10.1 Global Chronic Refractory Cough (CRC) Treatment Forecast by Regions (2024-2029)
  10.1.1 Global Chronic Refractory Cough (CRC) Treatment Forecast by Regions (2024-2029)
  10.1.2 Americas Chronic Refractory Cough (CRC) Treatment Forecast
  10.1.3 APAC Chronic Refractory Cough (CRC) Treatment Forecast
  10.1.4 Europe Chronic Refractory Cough (CRC) Treatment Forecast
  10.1.5 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Forecast
10.2 Americas Chronic Refractory Cough (CRC) Treatment Forecast by Country (2024-2029)
  10.2.1 United States Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.2.2 Canada Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.2.3 Mexico Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.2.4 Brazil Chronic Refractory Cough (CRC) Treatment Market Forecast
10.3 APAC Chronic Refractory Cough (CRC) Treatment Forecast by Region (2024-2029)
  10.3.1 China Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.3.2 Japan Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.3.3 Korea Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.3.4 Southeast Asia Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.3.5 India Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.3.6 Australia Chronic Refractory Cough (CRC) Treatment Market Forecast
10.4 Europe Chronic Refractory Cough (CRC) Treatment Forecast by Country (2024-2029)
  10.4.1 Germany Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.4.2 France Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.4.3 UK Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.4.4 Italy Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.4.5 Russia Chronic Refractory Cough (CRC) Treatment Market Forecast
10.5 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Forecast by Region (2024-2029)
  10.5.1 Egypt Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.5.2 South Africa Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.5.3 Israel Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.5.4 Turkey Chronic Refractory Cough (CRC) Treatment Market Forecast
  10.5.5 GCC Countries Chronic Refractory Cough (CRC) Treatment Market Forecast
10.6 Global Chronic Refractory Cough (CRC) Treatment Forecast by Type (2024-2029)
10.7 Global Chronic Refractory Cough (CRC) Treatment Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Merck Company Information
  11.1.2 Merck Chronic Refractory Cough (CRC) Treatment Product Offered
  11.1.3 Merck Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Merck Main Business Overview
  11.1.5 Merck Latest Developments
11.2 Nerre Therapeutics
  11.2.1 Nerre Therapeutics Company Information
  11.2.2 Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Product Offered
  11.2.3 Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Nerre Therapeutics Main Business Overview
  11.2.5 Nerre Therapeutics Latest Developments
11.3 Bellus Health
  11.3.1 Bellus Health Company Information
  11.3.2 Bellus Health Chronic Refractory Cough (CRC) Treatment Product Offered
  11.3.3 Bellus Health Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Bellus Health Main Business Overview
  11.3.5 Bellus Health Latest Developments
11.4 Attenua
  11.4.1 Attenua Company Information
  11.4.2 Attenua Chronic Refractory Cough (CRC) Treatment Product Offered
  11.4.3 Attenua Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Attenua Main Business Overview
  11.4.5 Attenua Latest Developments
11.5 Respivant Sciences
  11.5.1 Respivant Sciences Company Information
  11.5.2 Respivant Sciences Chronic Refractory Cough (CRC) Treatment Product Offered
  11.5.3 Respivant Sciences Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Respivant Sciences Main Business Overview
  11.5.5 Respivant Sciences Latest Developments
11.6 Shionogi
  11.6.1 Shionogi Company Information
  11.6.2 Shionogi Chronic Refractory Cough (CRC) Treatment Product Offered
  11.6.3 Shionogi Chronic Refractory Cough (CRC) Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Shionogi Main Business Overview
  11.6.5 Shionogi Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Chronic Refractory Cough (CRC) Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Speech Therapy
Table 3. Major Players of Physiotherapy
Table 4. Chronic Refractory Cough (CRC) Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Chronic Refractory Cough (CRC) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Type (2018-2023)
Table 7. Chronic Refractory Cough (CRC) Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Chronic Refractory Cough (CRC) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Application (2018-2023)
Table 10. Global Chronic Refractory Cough (CRC) Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Player (2018-2023)
Table 12. Chronic Refractory Cough (CRC) Treatment Key Players Head office and Products Offered
Table 13. Chronic Refractory Cough (CRC) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Chronic Refractory Cough (CRC) Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Regions (2018-2023)
Table 18. Global Chronic Refractory Cough (CRC) Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Chronic Refractory Cough (CRC) Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Country (2018-2023)
Table 22. Americas Chronic Refractory Cough (CRC) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Type (2018-2023)
Table 24. Americas Chronic Refractory Cough (CRC) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Application (2018-2023)
Table 26. APAC Chronic Refractory Cough (CRC) Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Region (2018-2023)
Table 28. APAC Chronic Refractory Cough (CRC) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Type (2018-2023)
Table 30. APAC Chronic Refractory Cough (CRC) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Application (2018-2023)
Table 32. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Country (2018-2023)
Table 34. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Type (2018-2023)
Table 36. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Chronic Refractory Cough (CRC) Treatment
Table 45. Key Market Challenges & Risks of Chronic Refractory Cough (CRC) Treatment
Table 46. Key Industry Trends of Chronic Refractory Cough (CRC) Treatment
Table 47. Global Chronic Refractory Cough (CRC) Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Chronic Refractory Cough (CRC) Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Chronic Refractory Cough (CRC) Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Chronic Refractory Cough (CRC) Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Merck Details, Company Type, Chronic Refractory Cough (CRC) Treatment Area Served and Its Competitors
Table 52. Merck Chronic Refractory Cough (CRC) Treatment Product Offered
Table 53. Merck Chronic Refractory Cough (CRC) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Merck Main Business
Table 55. Merck Latest Developments
Table 56. Nerre Therapeutics Details, Company Type, Chronic Refractory Cough (CRC) Treatment Area Served and Its Competitors
Table 57. Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Product Offered
Table 58. Nerre Therapeutics Main Business
Table 59. Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Nerre Therapeutics Latest Developments
Table 61. Bellus Health Details, Company Type, Chronic Refractory Cough (CRC) Treatment Area Served and Its Competitors
Table 62. Bellus Health Chronic Refractory Cough (CRC) Treatment Product Offered
Table 63. Bellus Health Main Business
Table 64. Bellus Health Chronic Refractory Cough (CRC) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Bellus Health Latest Developments
Table 66. Attenua Details, Company Type, Chronic Refractory Cough (CRC) Treatment Area Served and Its Competitors
Table 67. Attenua Chronic Refractory Cough (CRC) Treatment Product Offered
Table 68. Attenua Main Business
Table 69. Attenua Chronic Refractory Cough (CRC) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Attenua Latest Developments
Table 71. Respivant Sciences Details, Company Type, Chronic Refractory Cough (CRC) Treatment Area Served and Its Competitors
Table 72. Respivant Sciences Chronic Refractory Cough (CRC) Treatment Product Offered
Table 73. Respivant Sciences Main Business
Table 74. Respivant Sciences Chronic Refractory Cough (CRC) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Respivant Sciences Latest Developments
Table 76. Shionogi Details, Company Type, Chronic Refractory Cough (CRC) Treatment Area Served and Its Competitors
Table 77. Shionogi Chronic Refractory Cough (CRC) Treatment Product Offered
Table 78. Shionogi Main Business
Table 79. Shionogi Chronic Refractory Cough (CRC) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Shionogi Latest Developments

LIST OF FIGURES

Figure 1. Chronic Refractory Cough (CRC) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Chronic Refractory Cough (CRC) Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Chronic Refractory Cough (CRC) Treatment Sales Market Share by Country/Region (2022)
Figure 8. Chronic Refractory Cough (CRC) Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Type in 2022
Figure 10. Chronic Refractory Cough (CRC) Treatment in Hospital
Figure 11. Global Chronic Refractory Cough (CRC) Treatment Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Chronic Refractory Cough (CRC) Treatment in Clinic
Figure 13. Global Chronic Refractory Cough (CRC) Treatment Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Chronic Refractory Cough (CRC) Treatment in Others
Figure 15. Global Chronic Refractory Cough (CRC) Treatment Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Application in 2022
Figure 17. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Player in 2022
Figure 18. Global Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Chronic Refractory Cough (CRC) Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Chronic Refractory Cough (CRC) Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Chronic Refractory Cough (CRC) Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Chronic Refractory Cough (CRC) Treatment Value Market Share by Country in 2022
Figure 24. United States Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Application in 2022
Figure 31. China Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Chronic Refractory Cough (CRC) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Chronic Refractory Cough (CRC) Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Chronic Refractory Cough (CRC) Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Chronic Refractory Cough (CRC) Treatment Market Size Market Share Forecast by Application (2024-2029)


More Publications